April 2, 2020 – Medicinal Genomics to Donate a Portion of CannMed Tickets Sales to COVID-19 ResponsePremier medical & scientific cannabis conference to contribute 10% of ticket sales to support CDC Emergency Response Fund to help mitigate the public health threat
March 10, 2020 – Medicinal Genomics Signs on as Agilent US Value Added Reseller
February 27, 2020 – Medicinal Genomics Announces New PathoSEEK® Aspergillus Multiplex Assay to Streamline Cannabis Testing New 5-color assay independently identifies four species of pathogenic Aspergillus plus a cannabis control in just one qPCR reaction
January 30, 2020 – Medicinal Genomics Expands Global Reach with Distribution Partners in South America and Southeast Asia Leading genomics firm driving adoption of biotechnology to improve cannabis production in geographies around the world
January 6, 2020 – Medicinal Genomics Partners with Analogic Solutions for Distribution of its Cannabis Genomic Breeding, Optimization, and Testing Platform to the Caribbean Leading local firm driving adoption of biotechnology for yield, safety, and consistency throughout the region
December 10, 2019 – Eurofins Scientific, Medicinal Genomics Partner on World’s Most Comprehensive, Informative Cannabis SNP Chip New SNP chip will help breeders create hemp cultivars that meet new USDA regulations.
November 15, 2019 – Medicinal Genomics Signs Tagaca SRL as Distribution Partner for its Genomic Breeding and Testing Platform in Uruguay Major Uruguay biotech distributor sees global potential for their country’s cannabis crop.
September 10, 2019 – Medicinal Genomics, Arbor Biosciences Partner on Marker Discovery and Genotyping in Cannabis Together the organizations will generate a comprehensive panel for analyzing unique genetic signatures in cannabis strains.
August 20, 2019 – Medicinal Genomics Announces Raphael Mechoulam, the Father of Cannabis Research, Will Headline CannMed 2019, September 23-24, in Pasadena, CA Professor Mechoulam, who co-created CannMed, will keynote its fourth annual gathering along with more than 50 of the greatest minds in cannabis
April 29, 2019 – Medicinal Genomics Partners with Eldan to Distribute its Cannabis Testing and Genomics Solutions to the Israeli Market Israel’s Leading Distributor To Begin Supplying Israel’s Rapidly Growing Medicinal Cannabis Industry with MGC’s Cutting Edge U.S. Technology
April 18, 2019 – Medicinal Genomics announces Cannabis Pan-Genome project, a major advance in genetics for cannabis breeding Pacific Biosciences Sequel II System genetic analysis platform to catalog structural variants—the genetic hotspots—governing cannabis chemotype
January 22, 2019 – Medicinal Genomics Releases Industry’s First Comprehensive Cannabis Reference Genome Genetic milestone in mapping the cannabis genome to be made public to accelerate research and commercialization
January 3, 2019 – Medicinal Genomics Partners with Eiken Chemical for Cannabis Testing to Drive Higher Yield, Ag Productivity Integrating LAMP technology with MGC proprietary genetics accelerates accurate detection of cannabis genes, genotypes, pests and pathogens
October 17, 2018 – CannMed 2018, Country’s Premier Medical Cannabis Conference, Opens October 22nd – 24th at UCLA Luskin Center Third Annual Conference moves west to reflect growing importance of California’s cannabis market, opens with Career Fair hosted by California’s EDD
October 11, 2018 – California Employment Development Department and CannMed 2018 host inaugural Cannabis Career Fair EDD to showcase administrative services, business assistance and more than 75 cannabis companies hiring at 3rd Annual CannMed Medical Cannabis Conference
July 24, 2018 – CannMed 2018 Conference Features the Greatest Minds in Cannabis Research, Medicine, and Cultivation The 3rd Annual CannMed event features global industry leaders, physicians, clinicians, scientists, policy makers, laboratory professionals, attorneys, blockchain leaders, and media, gathering to discuss developments in cannabis medicine, legalization, opioids treatment through cannabis, pain management, cryptocurrency technology, and more.
January 16, 2018 – Medicinal Genomics Partners with DASH Cryptocurrency for CannMed 2018 Cannabis Conference The 3rd Annual CannMed Conference will join leaders in cannabis research, medicine, and technology to discuss the use of cannabis-based therapies for a variety of medical conditions, innovations in cultivation, and the intersection of cryptocurrency and cannabis.
March 30, 2017 – CannMed 2017 Premier Medical Marijuana Conference to Feature Global Industry Leaders, Physicians, Scientists, Politicians, Athletes, Attorneys, and Media Gathering to Discuss Medicine, Legalization, Opioids vs. Cannabis, Pain Management, and More Conference to Be Live Streamed Including Featured Speakers, Dr. Raphael Mechoulam (The “Father of Cannabis Research”), Dr. Michael Dor, Dr. Bonni Goldstein, and Former NFL Athletes
March 28, 2017 – CannMed 2017 Conference will Host Red-Carpet Event and Screening of Film in Honor of Local Teen with Rare Cancer Local Teenage Patient Fulfilled Dream of Becoming a Filmmaker with Help from Hollywood A-List Actors and Directors and the Make A Film Foundation
March 22, 2017 – CannMed 2017 Conference to Feature Former NFL Players Leading Panel Discussion on Medical Marijuana Use in Professional Sports Former NFL players Ricky Williams, Nate Jackson, Eben Britton, and Lance Johnstone join leading physicians to discuss medical cannabis as a viable alternative to often addictive opiates
February 23, 2017 – Courtagen Receives Notice of Allowance for a Genetically Targeted Pain Therapy Patent in the U.S. Patent targets personalized medicine approach matching genetic markers for chronic pain with therapeutic drugs, including the cannabis-derived compound cannabidiol
Our Microbial Detection Platform is the most accurate, affordable, and scalable solution for California testing labs. Only two reactions needed to test for all six required pathogens (A. flavus, A. fumigatus, A. niger, A. terreus, Salmonella STEC).